Literature DB >> 16510291

TGFbeta1 regulates the inflammatory response during chronic neurodegeneration.

Delphine Boche1, Colm Cunningham, Fabian Docagne, Helen Scott, V Hugh Perry.   

Abstract

The ME7 model of murine prion disease shows an atypical inflammatory response characterized by morphologically activated microglia and an anti-inflammatory cytokine profile with a marked expression of TGFbeta1. The investigation of the role of TGFbeta1 during a time course disease shows that its expression is correlated with (i) the onset of behavioral abnormalities, (ii) increased activated microglia, (iii) thickening of the basement membrane, and (iv) is associated with increased PrP(sc) deposition. Increasing TGFbeta1 using an adenoviral vector has no significant impact on prion-associated behavioral impairments or on neuropathology. In contrast, inhibition of TGFbeta1 activity using an adenovirus expressing decorin induces severe cerebral inflammation, expression of inducible nitric oxide synthase and acute neuronal death in prion-diseased animals only. These data suggest that TGFbeta1 plays a critical role in the downregulation of microglial responses minimizing brain inflammation and thus avoiding exacerbation of brain damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510291     DOI: 10.1016/j.nbd.2006.01.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 2.  Role of microglia in neuronal degeneration and regeneration.

Authors:  Lisa Walter; Harald Neumann
Journal:  Semin Immunopathol       Date:  2009-09-09       Impact factor: 9.623

Review 3.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

4.  Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampus.

Authors:  James J Bae; Yun-Yan Xiang; Alonso Martinez-Canabal; Paul W Frankland; Burton B Yang; Wei-Yang Lu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-09-15

5.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

6.  Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

Authors:  Elina Zotova; James Ar Nicoll; Raj Kalaria; Clive Holmes; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2010-01-22       Impact factor: 6.982

7.  Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury.

Authors:  Galina Dvoriantchikova; David Barakat; Roberta Brambilla; Christian Agudelo; Eleut Hernandez; John R Bethea; Valery I Shestopalov; Dmitry Ivanov
Journal:  Eur J Neurosci       Date:  2009-07-09       Impact factor: 3.386

Review 8.  TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.

Authors:  Filippo Caraci; Giuseppe Battaglia; Valeria Bruno; Paolo Bosco; Viviana Carbonaro; Maria Laura Giuffrida; Filippo Drago; Maria Angela Sortino; Ferdinando Nicoletti; Agata Copani
Journal:  CNS Neurosci Ther       Date:  2009-11-19       Impact factor: 5.243

9.  Neuronal and astroglial TGFβ-Smad3 signaling pathways differentially regulate dendrite growth and synaptogenesis.

Authors:  Chuan-Yong Yu; Wei Gui; Hui-Yan He; Xiao-Shan Wang; Jian Zuo; Lin Huang; Nong Zhou; Kai Wang; Yu Wang
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

10.  Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.

Authors:  Keiko Sakai; Rie Hasebe; Yusuke Takahashi; Chang-Hyun Song; Akio Suzuki; Takeshi Yamasaki; Motohiro Horiuchi
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.